Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa

Mucosal Immunology

Volumn 2, Issue 5, 2009, Pages 403-411

  Khader, S A ^a   Gaffen, S L ^a   Kolls, J K ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b Department of Genetics ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 22; PERTUSSIS VACCINE;

ADAPTIVE IMMUNITY; BACTERIAL INFECTION; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; EFFECTOR CELL; HUMAN; IMMUNIZATION; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MEMORY T LYMPHOCYTE; MOUTH INFECTION; MUCOSAL IMMUNITY; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; VIRUS INFECTION;

EID: 69249145293     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2009.100     Document Type: Review

References (98)

1. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A. & Coffman, R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 248-2357 (1986).
2. Garvy, B.A., Wiley, J.A., Gigliotti, F. & Harmsen, A.G. Protection against Pneumocystis carinii pneumonia by antibodies generated from either T helper 1 or T helper 2 responses. Infect. Immun. 65, 5052-5056 (1997).
3. Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233-240 (2005).
4. Harrington, L.E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132 (2005).
5. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
6. Dong, C. Diversification of T-helper-cell lineages: Finding the family root of IL-17-producing cells. Nat. Rev. Immunol. 6, 329-333 (2006).
7. Nurieva, R. et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448, 480-483 (2007).
8. Korn, T. et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448, 484-487 (2007).
9. Chung, Y. et al. Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes. Cell Res. 16, 902-907 (2006).
10. Liang, S.C. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271-2279 (2006).
11. Yao, Z. et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3, 811-821 (1995).
12. Ouyang, W., Kolls, J.K. & Zheng, Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28, 454-467 (2008).
13. Dong, C. Regulation and pro-inflammatory function of interleukin-17 family cytokines. Immunol. Rev. 226, 80-86 (2008).
14. Diveu, C., McGeachy, M.J. & Cua, D.J. Cytokines that regulate autoimmunity. Curr. Opin. Immunol. 20, 663-668 (2008).
15. Kikly, K., Liu, L., Na, S. & Sedgwick, J.D. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr. Opin. Immunol. 18, 670-675 (2006).
16. Ye, P. et al. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell Mol. Biol. 25, 335-340 (2001).
17. Ye, P. et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194, 519-527 (2001).
18. Happel, K.I. et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202, 761-769 (2005).
19. Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V.K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485-517 (2009).
20. Ivanov, II et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121-1133 (2006).
21. Yang, X.O. et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28, 29-39 (2008).
22. Chen, Z., Laurence, A. & O ' Shea, J.J. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin. Immunol. 19, 400-408 (2007).
23. de Beaucoudrey, L. et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J. Exp. Med. 205, 1543-1550 (2008).
24. Milner, J.D. et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452 773-776 (2008).
25. van Beelen, A.J. et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27, 660-669 (2007).
26. Gerosa, F. et al. Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J. Exp. Med. 205, 1447-1461 (2008).
27. Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238 (2006).
28. Khader, S.A. et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8, 369-377 (2007).
29. Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14, 282-289 (2008).
30. Volpe, E. et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat. Immunol. 9, 650-657 (2008).
31. Batten, M. et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7, 929-936 (2006).
32. Stumhofer, J.S. et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7, 937-945 (2006).
33. Laurence, A. et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371-381 (2007).
34. Khayrullina, T., Yen, J. H., Jing, H. & Ganea, D. In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. J. Immunol. 181, 721-735 (2008).
35. Siciliano, N.A., Skinner, J.A. & Yuk, M.H. Bordetella bronchiseptica modulates macrophage phenotype leading to the inhibition of CD4+ T cell proliferation and the initiation of a Th17 immune response. J. Immunol. 177, 7131-7138 (2006).
36. Woolard, M.D., Hensley, L.L., Kawula, T.H. & Frelinger, J.A. Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells. Infect. Immun. 76, 2651-2659 (2008).
37. Chizzolini, C. et al. Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood 112, 3696-3703 (2008).
38. Boniface, K. et al. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J. Exp. Med. 206, 535-548 (2009).
39. Napolitani, G., Acosta-Rodriguez, E.V., Lanzavecchia, A. & Sallusto, F. Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-gamma production by memory CD4+ T cells. Eur J. Immunol. 39 1301-1312 (2009).
40. Happel, K.I. et al. Cutting edge: Roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170, 4432-4436 (2003).
41. Khader, S.A. et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J. Immunol. 175, 788-795 (2005).
42. Mitchell, P. et al. Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development. Infect. Immun. 75, 810-819 (2007).
43. Butchar, J.P. et al. Francisella tularensis induces IL-23 production in human monocytes. J. Immunol. 178, 4445-4454 (2007).
44. Siegemund, S. et al. Production of IL-12, IL-23 and IL-27p28 by bone marrow-derived conventional dendritic cells rather than macrophages after LPS/TLR4-dependent induction by Salmonella enteritidis. Immunobiology 212, 739-750 (2007).
45. Fedele, G. et al. Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis differently modulate human dendritic cell functions resulting in divergent prevalence of Th17-polarized responses. J. Immunol. 181, 208-216 (2008).
46. Kim, B., Sarangi, P.P., Azkur, A.K., Kaistha, S.D. & Rouse, B.T. Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responses. Microbes Infect. 10, 302-312 (2008).
47. LeibundGut-Landmann, S. et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8, 630-638 (2007).
48. Siegemund, S. & Alber, G. Cryptococcus neoformans activates bone marrow-derived conventional dendritic cells rather than plasmacytoid dendritic cells and down-regulates macrophages. FEMS Immunol. Med. Microbiol. 52, 417-427 (2008).
49. Zelante, T. et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J. Immunol. 37, 2695-2706 (2007).
50. Lockhart, E., Green, A. M. & Flynn, J. L. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177, 4662-4669 (2006).
51. Umemura, M. et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J. Immunol. 178, 3786-3796 (2007).
52. Peng, M. Y. et al. Interleukin 17-producing gammadelta T cells increased in patients with active pulmonary tuberculosis. Cell. Mol. Immunol. 5, 203-208 (2008).
53. Michel, M. L. et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204, 995-1001 (2007).
54. Satoh-Takayama, N. et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29, 958-970 (2008).
55. Cella, M. et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722-725 (2009).
56. Ferretti, S., Bonneau, O., Dubois, G. R., Jones, C. E. & Trifilieff, A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 170, 2106-2112 (2003).
57. Takatori, H. et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 206, 35-41 (2009).
58. Cupedo, T. et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat. Immunol. 10, 66-74 (2009).
59. Luci, C. et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 10, 75-82 (2009).
60. Sanos, S. L. et al. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 10, 83-91 (2009).
61. Fossiez, F. et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183, 2593-2603 (1996).
62. Jones, C. E. & Chan, K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocytecolony-stimulating factor by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 26, 748-753 (2002).
63. Laan, M., Lotvall, J., Chung, K.F. & Linden, A. IL-17-induced cytokine release in human bronchial epithelial cells in vitro: Role of mitogenactivated protein (MAP) kinases. Br. J. Pharmacol. 133 200-206 (2001).
64. Kao, C.Y. et al. IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J. Immunol. 173, 3482-3491 (2004).
65. Aujla, S.J. et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14, 275-281 (2008).
66. Huang, F. et al. Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells. J. Immunol. 179, 6504-6513 (2007).
67. Mangan, P.R. et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441, 231-234 (2006).
68. Ishigame, H. et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30, 108-119 (2009).
69. Yu, J.J., Ruddy, M.J., Conti, H.R., Boonanantanasarn, K. & Gaffen, S.L. The IL-17 receptor plays a gender-dependent role in host protection against P. gingivalis -induced periodontal bone loss. Infect. Immun. 76, 4206-4213 (2008).
70. Gaffen, S.L. & Hajishengallis, G. A new inflammatory cytokine on the block: Re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J. Dent. Res. 87, 817-828 (2008).
71. Carbonetti, N.H. Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease. Curr. Opin. Pharmacol. 7, 272-278 (2007).
72. Luzza, F. et al. Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori -infected human gastric mucosa. J. Immunol. 165, 5332-5337 (2000).
73. Caruso, R. et al. IL-23-mediated regulation of IL-17 production in Helicobacter pylori -infected gastric mucosa. Eur J. Immunol. 38, 470-478 (2008).
74. Wu, Q. et al. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect. 9, 78-86 (2007).
75. Raffatellu, M. et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat. Med. 14, 421-428 (2008).
76. Huang, W., Na, L., Fidel, P.L. & Schwarzenberger, P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190, 624-631 (2004).
77. Dongari-Bagtzoglou, A. & Fidel, P.L. Jr. The host cytokine responses and protective immunity in oropharyngeal candidiasis. J. Dent. Res. 84, 966-977 (2005).
78. Conti, H.R. et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206, 299-311 (2009).
79. Farah, C.S., Hu, Y., Riminton, S. & Ashman, R. B. Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene-targeting. Oral Microbiol. Immunol. 21, 252-255 (2006).
80. van de Veerdonk, F.L. et al. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 5, 329-340 (2009).
81. Eyerich, K. et al. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J. Invest. Dermatol. 128, 2640-2645 (2008).
82. Ma, C.S. et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J. Exp. Med. 205, 1551-1557 (2008).
83. Rudner, X.L., Happel, K.I., Young, E.A. & Shellito, J.E. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect. Immun. 75, 3055-3061 (2007).
84. Werner, J.L. et al. Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J. Immunol. 182, 4938-4946 (2009).
85. Romani, L. et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451 211-215 (2008).
86. Yue, F.Y. et al. Virus-specific interleukin-17-producing CD4+ T cells are detectable in early human immunodeficiency virus type 1 infection. J. Virol. 82, 6767-6771 (2008).
87. Arens, R. et al. Cutting edge: Murine cytomegalovirus induces a polyfunctional CD4 T cell response. J. Immunol. 180, 6472-6476 (2008).
88. Molesworth-Kenyon, S.J., Yin, R., Oakes, J.E. & Lausch, R.N. IL-17 receptor signaling influences virus-induced corneal inflammation. J. Leukoc. Biol. 83, 401-408 (2008).
89. Wiehler, S. & Proud, D. Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection. Am. J. Physiol. Lung. Cell Mol. Physiol. 293, L505-L515 (2007).
90. Hamada, H. et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J. Immunol. 182, 3469-3481 (2009).
91. Parham, C. et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699-5708 (2002).
92. Scriba, T.J. et al. Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J. Immunol. 180, 1962-1970 (2008).
93. Happel, K.I. et al. Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs. Infect. Immun. 73, 5782-5788 (2005).
94. Higgins, S.C., Jarnicki, A.G., Lavelle, E.C. & Mills, K.H. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 177, 7980-7989 (2006).
95. Malley, R. et al. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect. Immun. 74, 2187-2195 (2006).
96. Smiley, K.L. et al. Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G). J. Virol. 81, 3740-3748 (2007).
97. McNeal, M.M. et al. IFN-gamma is the only anti-rotavirus cytokine found after in vitro stimulation of memory CD4+ T cells from mice immunized with a chimeric VP6 protein. Viral. Immunol. 20, 571-584 (2007).
98. Dubin, P.J., McAllister, F. & Kolls, J.K. Is cystic fibrosis a TH17 disease? Inflamm. Res. 56, 221-227 (2007).